The incidence of chromogranin A defined endocrine cells decreases with tumour progression in gastric adenocarcinoma

Surg Oncol. 1995;4(5):255-60. doi: 10.1016/s0960-7404(10)80004-0.

Abstract

The immunohistochemical expression of chromogranin A (CGA) was investigated in 60 normal mucosas, 95 primary tumours and 38 metastatic lymph nodes. CGA was expressed in 100% of the normal mucosas, 61% of the primary tumours that were restricted within the submucosal layer, 21% of the primary tumours that invaded beyond the submucosal layer, and 11% of the metastatic lymph nodes. The 5-year survival rates in patients with negative and positive expression of CGA in primary tumours were 60.4% and 74.6%, respectively. These results indicate that endocrine cells occupy an integral part of gastric adenocarcinoma with regard to tumour progression.

MeSH terms

  • Adenocarcinoma / pathology*
  • Adenocarcinoma / secondary
  • Adult
  • Aged
  • Aged, 80 and over
  • Chromogranin A
  • Chromogranins / analysis*
  • Chromogranins / genetics
  • Disease Progression
  • Endocrine Glands / pathology*
  • Female
  • Gastric Mucosa / metabolism
  • Gastric Mucosa / pathology
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry
  • Lymphatic Metastasis / pathology
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Stomach Neoplasms / pathology*
  • Survival Rate

Substances

  • CHGA protein, human
  • Chromogranin A
  • Chromogranins